MAP2K7 (Mitogen-Activated Protein Kinase Kinase 7)

A dual-specificity kinase in the JNK signaling pathway, implicated in cancer, inflammation, and developmental disorders.

Gene Information Card

Symbol MAP2K7
Full Name Mitogen-Activated Protein Kinase Kinase 7
Gene Type Protein coding
Chromosomal Location 19p13.3
NCBI Gene ID 5609 ncbi.nlm.nih.gov/gene/5609
Ensembl ID ENSG00000176953
UniProt ID O14733
OMIM ID 603014
HGNC ID 6847
Aliases MKK7, JNKK2, PRKMK7, SAPKK4, MAPKK7

Description

MAP2K7 (Mitogen-Activated Protein Kinase Kinase 7) encodes a dual-specificity protein kinase that specifically phosphorylates and activates c-Jun N-terminal kinases (JNKs). It is a key component of the stress-activated protein kinase (SAPK) signaling cascade, responding to cytokines, environmental stress, and growth factors. MAP2K7 is essential for JNK activation and plays critical roles in cell proliferation, differentiation, apoptosis, and inflammation. Dysregulation of MAP2K7 is associated with various cancers, inflammatory diseases, and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Overexpression or gain-of-function mutations lead to constitutive JNK activation, promoting cell survival and proliferation. COSMIC; multiple studies
Inflammatory diseases Enhanced MAP2K7 activity amplifies JNK-mediated pro-inflammatory cytokine production. NCBI Gene; literature
Developmental disorders Loss-of-function mutations impair JNK signaling, affecting embryonic development and tissue homeostasis. OMIM; ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Lymph node 8.2 Medium
Brain (cortex) 6.1 Low
Liver 4.3 Low
Heart 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 9.5 Cervical cancer cell line
A549 7.8 Lung cancer cell line
HEK293 6.2 Embryonic kidney cell line
MCF7 5.1 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.625C>T (p.Arg209Trp) Missense <1% Reported in cancer; potential gain-of-function
c.371A>G (p.Asn124Ser) Missense <1% Found in developmental disorder; likely loss-of-function
c.1072_1073insA Frameshift <1% Truncating; loss-of-function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the kinase domain, reducing JNK activation.

Gain of Function (GOF)

Missense mutations in the activation loop that increase kinase activity and JNK signaling.

Dominant Negative (DN)

Mutations that produce inactive protein capable of interfering with wild-type MAP2K7 function.

Gene Ontology (GO)

• MAP kinase kinase activity • protein serine/threonine kinase activity
• JUN kinase kinase activity • ATP binding
• signal transduction • stress-activated MAPK cascade
• positive regulation of JNK cascade • apoptotic process

Pathways

• JNK signaling pathway
• MAPK signaling pathway
• TNF signaling pathway
• IL-17 signaling pathway
• Fc epsilon RI signaling pathway

Protein Summary

MAP2K7 (MKK7) is a 419-amino-acid dual-specificity kinase with an N-terminal docking domain and a C-terminal kinase domain. It specifically phosphorylates JNK1, JNK2, and JNK3 on Thr and Tyr residues. The protein is activated by upstream kinases such as MAP3K1/MEKK1 and MAP3K2/MEKK2. MAP2K7 is widely expressed, with highest levels in testis and lymphoid tissues. Its activity is tightly regulated by phosphorylation and protein-protein interactions.

Related Products

Product name Cat.No. Species Gene ID
MAP2K7 Knockout HEK293 Cell Line EDJ-KQ684 Human 5609 Details Get a Quote
MAP2K7 Knockout A-549 Cell Line EDJ-KQ19233 Human 5609 Details Get a Quote
MAP2K7 Knockout HCT 116 Cell Line EDJ-KQ19234 Human 5609 Details Get a Quote
MAP2K7 Knockout HeLa Cell Line EDJ-KQ19235 Human 5609 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: